Qualigen Therapeutics
QLGN
QLGN
27 hedge funds and large institutions have $3.58M invested in Qualigen Therapeutics in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
Holders
27
Holders Change
+11
Holders Change %
+68.75%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
6
Reduced
5
Closed
1
Calls
$507K
Puts
$1.1M
Net Calls
-$589K
Net Calls Change
-$589K
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$138K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$907K |
| 4 |
4
Morgan Stanley
New York
|
$7K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
26
Goldman Sachs
New York
| – | – | -24,768 | Closed |
|
27
JPMorgan Chase & Co
New York
| $0 | 1 | -5,599 | -100% |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 48 | -40 | -45% |
|
|
IA
29
IFP Advisors
Tampa,
Florida
| – | – | – | – |
|
|
CFGS
30
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|